Gossamer Bio, Inc. Profile Avatar - Palmy Investing

Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Gossamer Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Gossamer Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Gossamer Bio, Inc..

End of GOSS's Analysis
CIK: 1728117 CUSIP: 38341P102 ISIN: US38341P1021 LEI: - UEI: -
Secondary Listings
GOSS has no secondary listings inside our databases.